DNAAF2 Gene Primary Ciliary Dyskinesia Type 10 NGS Genetic DNA Test
Comprehensive Genetic Analysis for Respiratory and Reproductive Health
The DNAAF2 Gene Primary Ciliary Dyskinesia Type 10 NGS Genetic DNA Test represents a cutting-edge diagnostic approach for identifying genetic mutations associated with primary ciliary dyskinesia (PCD), a rare inherited disorder affecting ciliary function throughout the body. This specialized test utilizes next-generation sequencing technology to provide comprehensive analysis of the DNAAF2 gene, which plays a critical role in ciliary assembly and motility.
What This Advanced Genetic Test Measures
Our DNAAF2 Gene Primary Ciliary Dyskinesia Type 10 NGS Genetic DNA Test specifically targets and analyzes the DNAAF2 gene for pathogenic variants that disrupt normal ciliary function. The test detects:
- Point mutations, insertions, and deletions in the DNAAF2 gene
- Variants affecting ciliary dynein assembly factor 2 protein function
- Genetic alterations responsible for impaired mucociliary clearance
- Mutations leading to abnormal ciliary structure and motility
- Inherited genetic patterns associated with autosomal recessive PCD
Who Should Consider This Genetic Testing
This specialized genetic test is recommended for individuals presenting with symptoms suggestive of primary ciliary dyskinesia, including:
- Chronic respiratory infections beginning in infancy or childhood
- Persistent nasal congestion and sinusitis unresponsive to conventional treatments
- Recurrent middle ear infections and hearing complications
- Chronic cough with excessive mucus production
- Bronchiectasis development at an early age
- Neonatal respiratory distress requiring extended oxygen support
- Laterality defects such as situs inversus or heterotaxy
- Male infertility due to impaired sperm motility
- Female subfertility related to fallopian tube ciliary dysfunction
- Family history of primary ciliary dyskinesia or related respiratory conditions
Significant Benefits of DNAAF2 Genetic Testing
Undergoing the DNAAF2 Gene Primary Ciliary Dyskinesia Type 10 NGS Genetic DNA Test provides numerous clinical advantages:
- Accurate Diagnosis: Confirms or rules out genetic causes of respiratory symptoms
- Personalized Treatment Planning: Enables targeted management strategies for respiratory complications
- Family Planning Guidance: Provides crucial information for reproductive decision-making
- Early Intervention: Facilitates proactive management to prevent progressive lung damage
- Genetic Counseling: Supports informed family planning and risk assessment for relatives
- Comprehensive Analysis: NGS technology ensures thorough examination of the entire DNAAF2 gene
Understanding Your Test Results
Our genetic specialists provide comprehensive interpretation of your DNAAF2 test results:
- Positive Result: Identification of pathogenic variants confirms DNAAF2-related primary ciliary dyskinesia diagnosis, enabling targeted management and family screening
- Negative Result: No detected mutations in DNAAF2 gene, though other genetic causes of PCD may require additional testing
- Variant of Uncertain Significance: Genetic changes with unclear clinical impact may require further evaluation and family studies
- Carrier Status: Identification of individuals carrying one copy of mutated DNAAF2 gene with implications for family planning
Test Pricing and Availability
| Test Component | Price (USD) |
|---|---|
| DNAAF2 Gene Primary Ciliary Dyskinesia Type 10 NGS Genetic DNA Test | $700 |
| Discount Price | $500 |
Turnaround Time: 3 to 4 Weeks
Sample Type: Blood, Extracted DNA, or One Drop Blood on FTA Card
Pre-Test Requirements and Genetic Counseling
Before undergoing testing, patients should provide comprehensive clinical history related to respiratory symptoms and fertility concerns. We strongly recommend a genetic counseling session to develop a detailed pedigree chart documenting family members affected by respiratory disorders, fertility issues, or confirmed primary ciliary dyskinesia. This preparatory step ensures optimal test interpretation and personalized result discussion.
Nationwide Testing Availability
We proudly offer the DNAAF2 Gene Primary Ciliary Dyskinesia Type 10 NGS Genetic DNA Test across our extensive network of testing facilities throughout the United States. Our specialized genetic testing services are available in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose, ensuring convenient access for patients nationwide.
Take Control of Your Respiratory Health Today
Don’t let unexplained respiratory symptoms or fertility concerns remain unanswered. Our DNAAF2 genetic testing provides the clarity needed for proper diagnosis and effective management. Contact our genetic specialists today to schedule your comprehensive evaluation and take the first step toward understanding your genetic health.
Call or WhatsApp our genetic counseling team at +1(267) 388-9828 to book your DNAAF2 Gene Primary Ciliary Dyskinesia Type 10 NGS Genetic DNA Test and receive personalized guidance throughout your testing journey.
